GlassScriptPhysician profile
Anthony Peter Lomonaco
NPI 1326215823
$9,283.43
in general payments reported to CMS, 2019-2025
36 companies · $513 in 2025
The $513 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,116 · 2020: $1,313 · 2021: $731 · 2022: $1,868 · 2023: $1,114 · 2024: $628 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,255.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,730.44 | 2019-2025 | Proclaim, Eterna, Octrode |
| Spinal Simplicity, LLC | $1,090.41 | 2022 | |
| Boston Scientific Corporation | $826.49 | 2019-2025 | General - Pain Management, Superion Indirect Decompression System, Intracept |
| Painteq LLC | $522.75 | 2021-2024 | Painteq |
| Relievant Medsystems, INC. | $468.89 | 2022-2023 | Intracept |
| Vertos Medical, INC. | $367.87 | 2019-2024 | Mild Device Kit |
| Stimwave Technologies Incorporated | $364.14 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $246.40 | 2019-2023 | Relistor |
| Bioness INC | $157.86 | 2020 | |
| Vertiflex, INC. | $151.08 | 2019 | |
| Biotronik Nro, INC. | $146.08 | 2025 | Prospera |
| Nevro Corp. | $133.86 | 2019-2023 | Senza |
| Scilex Pharmaceuticals INC. | $112.60 | 2019-2020 | |
| Medtronic, INC. | $112.51 | 2022-2023 | Intellis Adaptivestim |
| Si-Bone, INC. | $100.44 | 2019-2024 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $98.04 | 2019-2021 | |
| Abbvie INC. | $74.43 | 2023 | |
| Novartis Pharmaceuticals Corporation | $57.97 | 2019 | |
| Saluda Medical Americas, INC. | $53.03 | 2023 | Evoke Scs |
| Pfizer INC. | $52.46 | 2019-2023 | |
| Kaleo, INC. | $42.08 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $41.47 | 2020-2021 | |
| Amneal Pharmaceuticals LLC | $36.40 | 2022 | |
| Ibsa Pharma INC. | $35.88 | 2023 | Tirosint, Licart |
| Bioventus LLC | $35.19 | 2019 | |
| Shionogi INC | $28.21 | 2019 | |
| Amgen INC. | $26.63 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $26.02 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $23.50 | 2019 | |
| Nalu Medical, INC. | $23.36 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $21.66 | 2022 | |
| Redhill Biopharma INC. | $18.60 | 2021 | |
| Convatec INC. | $16.82 | 2024 | |
| Zyla Life Sciences, INC. | $13.37 | 2019 | |
| Biodelivery Sciences International, INC. | $13.32 | 2019 | |
| Medtronic USA, INC. | $13.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Lomonaco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.